segmentation

Digital

Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.

Views & Analysis

Dividing patients into groups based on how they behave towards their condition aids understanding.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.